|
|
Eukaryotic Expression of Porcine IL-17 Gene and its Bioactivity |
Ding-hao DENG,Yong-le XIAO,Jian-xue TANG,Xing YANG,Rong GAO() |
Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education,Key Laboratory for Animal Disease Prevention and Food Safety of Sichuan Province,College of Life Sciences,Sichuan University,Chengdu 610064,China |
|
|
Abstract Objective: To study porcine interleukin-17(IL-17) eukaryotic expression and their biologic activity. Methods: The IL-17 gene was amplified by PCR and cloned into eukaryotic expression vector pVAX1,named PV17. PV17 was transfected into IPEC-J2 cells,HaCaT cells and L02 cells,thereafter the cells were collected on hours 24,48 and 72,the supernatants were collected on hours 48. Related genes expression levels in cells were analysed by qRT-PCR,bioactivity of antimicrobial peptides in supernatants were analyzed by bacteriostatic test in vitro. Results: The eukaryotic expression plasmid of the porcine IL-17 gene was constructed and transfected into the three eukaryotic cells,and could expressed in target cells. The expression levels of antimicrobial peptide genes (RegⅢ,S100A8 and BD2),JAK-STAT signaling pathway genes (JAK1,STAT1 and STAT3) and cytokine genes (IL-6,IL-12 and TNF-α) were significantly up-regulated. Furthermore,the supernatants have marked bacteriostatic effect on E. coli and S. aureus. Conclusion: The recombinant plasmid of the porcine IL-17 gene was constructed and expressed in target cells,and the expressed products elicited the significant increases of cytokines and antibacterial peptides,which manifested obvious antibacterial activities against E. coli and S. aureus drug-resistant bacteria,and facilitated the further development of porcine IL-17 as the antibacterial reagent.
|
Received: 19 March 2018
Published: 11 September 2018
|
|
Corresponding Authors:
Rong GAO
E-mail: gaorong96@163.com
|
|
|
[1] |
Aggarwal S, Ghilardi N, Xie M H , et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. Journal of Biological Chemistry, 2003,278(3):1910-1914.
doi: 10.1074/jbc.M207577200
|
|
|
[2] |
Rouvier E, Luciani M F, Mattei M G , et al. CTLA-8,cloned from an activated T cell,bearing AU-rich messenger RNA instability sequences,and homologous to a herpesvirus saimiri gene. The Journal of Immunology, 1993,150(12):5445-5456.
|
|
|
[3] |
Hartupee J, Liu C, Novotny M , et al. IL-17 enhances chemokine gene expression through mRNA stabilization. The Journal of Immunology, 2007,179(6):4135-4141.
doi: 10.4049/jimmunol.179.6.4135
pmid: 17785852
|
|
|
[4] |
Shen F, Gaffen S L . Structure-function relationships in the IL-17 receptor:implications for signal transduction and therapy. Cytokine, 2008,41(2):92-104.
doi: 10.1016/j.cyto.2007.11.013
|
|
|
[5] |
Meyer D M, Jesson M I, Li X , et al. Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor,CP-690,550,in rat adjuvant-induced arthritis. Journal of Inflammation, 2010,7(1):41.
doi: 10.1186/1476-9255-7-41
|
|
|
[6] |
Liang S C, Tan X Y, Luxenberg D P , et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. Journal of Experimental Medicine, 2006,203(10):2271-2279.
doi: 10.1084/jem.20061308
|
|
|
[7] |
Kim B S, Park Y J, Chung Y . Targeting IL-17 in autoimmunity and inflammation. Archives of Pharmacal Research, 2016,39(11):1537-1547.
doi: 10.1007/s12272-016-0823-8
pmid: 27576555
|
|
|
[8] |
Numasaki M, Watanabe M, Suzuki T , et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. The Journal of Immunology, 2005,175(9):6177-6189.
doi: 10.4049/jimmunol.175.9.6177
|
|
|
[9] |
Kao C Y, Huang F, Chen Y , et al. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-κB-dependent signaling pathway. The Journal of Immunology, 2005,175(10):6676-6685.
doi: 10.4049/jimmunol.175.10.6676
|
|
|
[10] |
Marks B R, Craft J. Barrier immunity and IL-17// Seminars in Immunology. Academic Press, 2009,21(3):164-171.
|
|
|
[11] |
Onishi R M, Gaffen S L . Interleukin-17 and its target genes:mechanisms of interleukin-17 function in disease. Immunology, 2010,129(3):311-321.
doi: 10.1111/j.1365-2567.2009.03240.x
pmid: 20409152
|
|
|
[12] |
Song X, Zhu S, Shi P , et al. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nature Immunology, 2011,12(12):1151-1158.
doi: 10.1038/ni.2155
|
|
|
[13] |
Cua D J, Tato C M . Innate IL-17-producing cells:the sentinels of the immune system. Nature Reviews Immunology, 2010,10(7):479-489.
doi: 10.1038/nri2800
pmid: 20559326
|
|
|
[14] |
Komiyama Y, Nakae S, Matsuki T , et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. The Journal of Immunology, 2006,177(1):566-573.
doi: 10.4049/jimmunol.177.1.566
pmid: 16785554
|
|
|
[15] |
周艳春, 方丹, 许燕璇 . 小鼠IL-17基因的克隆及其真核表达载体的构建. 海南医学, 2009,20(12):10-12.
|
|
|
[15] |
Zhou Y C, Fang D, Xu Y X . Molecular cloning of mouse IL-17 gene and construction of its eukaryotic expression vector. Hainan Medical Journal, 2009,20(12):10-12.
|
|
|
[16] |
Dirisala V R, Jeevan A, Ramasamy S K , et al. Molecular cloning,expression,and in silico structural analysis of guinea pig IL-17. Molecular Biotechnology, 2013,55(3):277-287.
doi: 10.1007/s12033-013-9679-z
pmid: 23813049
|
|
|
[17] |
熊艳芸, 谢琪辉, 罗廷荣 , 等. 广西巴马小型猪白细胞介素17基因的克隆及其序列分析. 西南农业学报, 2005,18(6):844-847.
|
|
|
[17] |
Xiong Y Y, Xie Q H, Luo T R , et al. Cloning and sequence analysis of interleukin-17 gene of Guangxi Bama mini pig. Southwest China Journal of Agricultural Sciences. 2005,18(6):844-847.
|
|
|
[18] |
何勇, 朱艳平, 岳锋 , 等. 猪白细胞介素17A基因的克隆与鉴定. 基因组学与应用生物学, 2017,( 11):4622-4626.
|
|
|
[18] |
He Y, Zhu Y P, Yue F , et al. Cloning and identification of porcine IL-17A gene. Genomics and Applied Biology, 2017,( 11):4622-4626.
|
|
|
[19] |
Isailovic N, Daigo K, Mantovani A , et al. Interleukin-17 and innate immunity in infections and chronic inflammation. Journal of Autoimmunity, 2015,60:1-11.
doi: 10.1016/j.jaut.2015.04.006
pmid: 25998834
|
|
|
[20] |
Korn T, Bettelli E, Oukka M , et al. IL-17 and Th17 cells. Annual Review of Immunology, 2009,27:485-517.
doi: 10.1146/annurev.immunol.021908.132710
|
|
|
[21] |
Xu S, Cao X . Interleukin-17 and its expanding biological functions. Cellular & Molecular Immunology, 2010,7(3):164-174.
doi: 10.1038/cmi.2010.21
pmid: 4002915
|
|
|
[22] |
Katoh S, Kitazawa H, Shimosato T , et al. Cloning and characterization of swine interleukin-17,preferentially expressed in the intestines. Journal of Interferon & Cytokine Research, 2004,24(9):553-559.
doi: 10.1089/1079990041992721
pmid: 15450131
|
|
|
[23] |
Radek K, Gallo R . Antimicrobial peptides:natural effectors of the innate immune system//Seminars in Immunopathology. Springer-Verlag, 2007,29(1):27-43.
|
|
|
[24] |
Kao C Y, Chen Y, Thai P , et al. IL-17 markedly up-regulates β-defensin-2 expression in human airway epithelium via JAK and NF-κB signaling pathways. The Journal of Immunology, 2004,173(5):3482-3491.
doi: 10.4049/jimmunol.173.5.3482
|
|
|
[25] |
Leonard W J, O'Shea J J . Jaks and STATs:biological implications. Annual Review of Immunology, 1998,16(1):293-322.
doi: 10.1146/annurev.immunol.16.1.293
pmid: 9597132
|
|
|
[26] |
Rane S G, Reddy E P . Janus kinases:components of multiple signaling pathways. Oncogene, 2000,19(49):5662-5679.
doi: 10.1038/sj.onc.1203925
pmid: 11114747
|
|
|
[27] |
Egwuagu C E . STAT3 in CD4+ T helper cell differentiation and inflammatory diseases . Cytokine, 2009,47(3):149-156.
doi: 10.1016/j.cyto.2009.07.003
pmid: 2733795
|
|
|
[28] |
Lin H W, Thompson J W, Morris K C , et al. Signal transducers and activators of transcription:STATs-mediated mitochondrial neuroprotection. Antioxidants & Redox Signaling, 2011,14(10):1853-1861.
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|